HealthQuant

REAL Physician Influence. Time to bring your KOL programming into the digital age! Tweets by @chimoose

[HealthQuant @HealthQuant]

Looking to find the perfect combination of strengths in KOLs and online influencers? Our latest blog post uncovers the secrets of multi-layered, segmented influencer lists. Stay tuned for expert insights! #KOL #MedAffairs #PharmaMarketing #MedTech https://t.co/8VDFRvfxGl

[HealthQuant @HealthQuant]

This could come in handy!

[Curiosity @CuriosityonX]

If you ever get lost in the Milky Way galaxy, this is your map to get back to EARTH.

[LARVOL @Larvol]

Ahead of the @ASCO-2025, @Larvol CLIN spotlights the top companies driving the future of cancer research.

Get the latest #ASCO25 updates as they happen: https://t.co/051z3BNE4z

#LARVOL #CancerResearch #Oncology #ClinicalTrials #CancerData #OncologyInsights | @ADesaiMD | @HHorinouchi | @DrRiyazShah | @FordePatrick | @lungoncdoc | @matteolambe | @ErikaHamilton9 | @PTarantinoMD | @DrChoueiri | @AndreaNecchi | @GillSharlene | @mtmdphd | @SuyogCancer

[HealthQuant @HealthQuant]

@tapshah21 Will do! Thank you, Tapan.

[HealthQuant @HealthQuant]

@tapshah21 Hi Tapan! Yesterday my app stopped returning user data when calling the X ID user endpoint. Nothing in the documentation implies that was intentionally deprecated; can you please help?

[HealthQuant @HealthQuant]

@isabelzam95 That's amazing - Congratulations!

[HealthQuant @HealthQuant]

PS I’ve had a Basic plan for a couple of years and have had no problems thus far …

[HealthQuant @HealthQuant]

@chrisparkX Chris, can you help me out? My app that makes API calls for user data based on Twitter ID stopped working yesterday. Documentation still says that should work w/my basic plan. Any ideas?

[HealthQuant @HealthQuant]

@XDevelopers It appears that you've changed the API endpoints for USER queries from the basic subscription. Can you confirm? That's not anywhere in the documentation.

[HealthQuant @HealthQuant]

Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch. https://t.co/PEdqmhbDpi #pharma #feedly via @BioPharmaDive

[HealthQuant @HealthQuant]

This is one to watch: Startup led by John Maraganore raises $135M to build ‘future of RNAi’ https://t.co/u9wJjB31sR #pharma #feedly #biotech

[HealthQuant @HealthQuant]

2/2 But July, August and September of 2024 were each significantly higher than the same months in 2023. I'm encouraged that doctors are coming back. We'll keep watching! #MedTwitter #HCSM #HCSMEU

[HealthQuant @HealthQuant]

Interesting #MedTwitter stats: Comparing monthly twitter posts from global doctors, Posts from January-June of 2023 and 2024, physician posts were slightly down (February was actually up 2%). 1/2

[HealthQuant @HealthQuant]

Thanks @BioPharmaDive! Which conferences will YOU be attending? https://t.co/6cbGvSmOrc #Pharma #Biotech #PharmaMarketing

[HealthQuant @HealthQuant]

Man, that is a tough analysis - but it's hard to argue. We have to find different ways ...

[Andrew Joseph @DrewQJoseph]

The Bluebird layoffs this week "offered another reminder that groundbreaking genetic medicines capable of transforming the lives of people with inherited disease are not now — and may never become — a sustainable business."

via @adamfeuerstein https://t.co/VnEOWPJM5j

[Houston Methodist @MethodistHosp]

Here are some things every guy should know about the most commonly diagnosed cancer in men. https://t.co/fYe8Qi5u94

[HealthQuant @HealthQuant]

Thanks to @JNJInnovMed for their Transparency Report - and to @brianreid's Cost Curve newsletter for pointing us to it!

[Greg Matthews @chimoose]

Kudos to @JNJInnovMed for their excellent & comprehensive Transparency Report, which Cost Curve (@brianreid) calls the best in the industry. https://t.co/Vvhrl6Aq6V #Pharma #HealthInnovation #DrugPricing

[HealthQuant @HealthQuant]

Nice work by @EliLillyandCo on their #Olympics message: https://t.co/yjbGakxBLM

[HealthQuant @HealthQuant]

Did you ever wonder if cardiologists around the world are still active on X/Twitter? They are. Contact us at [email protected] for more information! https://t.co/cuzjccRkhH

[HealthQuant @HealthQuant]

Indeed - #Pharma winds up looking like the bad guys - when they're really just taking the fall for out-of-control #PBMs.

[Antonio Ciaccia @A_Ciaccia]

PBMs are supposed to be the superheroes fighting high drug prices, but perverse incentives often make actual low prices their kryptonite.

Kudos to @RebeccaDRobbins @ReedAbelson for a complete undressing of our dysfunctional prescription drug marketplace. https://t.co/rHOM16AShW

[HealthQuant @HealthQuant]

This one absolutely does NOT pass the sniff test - rest assured that we'll be doing some fact-checking!! | Many docs who tweeted product endorsements also took money from manufacturers, analysis shows | by @pharmalot https://t.co/FTXZhFZswH